| The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. | |
| | |
MedLine Citation:
|
PMID: 16595635 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Fas ligand (FasL) is a key death factor of cytotoxic T lymphocytes and natural killer cells. It is stored intracellularly as a transmembrane protein of secretory lysosomes. Upon activation, these vesicles are transported to the cytotoxic immunological synapse (IS), and FasL becomes exposed to the cell surface to trigger cell death through ligation of its receptor Fas (CD95) on the target cell. We propose that the FasL-associated adaptor protein Nck is involved in the actin-dependent transport of FasL-bearing secretory lysosomes to the IS. Nck binds to the proline-rich portion of FasL and alters its subcellular distribution when coexpressed in 293T cells. In T lymphocytes, endogenous Nck partially colocalizes with lysosome-associated FasL. When T cell clones or lines are exposed to target cells, both proteins and other components of secretory lysosomes (i.e., granzyme B or cathepsin D) are transported to the cell-cell interface. The present data suggest that T cell receptor engagement provokes a rapid, tyrosine kinase- and actin-dependent transport of Nck-associated FasL-carrying lysosomes to the contact area. Our observations support the previous notion that the unique cytoplasmic tail of FasL is crucial for its directed transport to the cell surface and into the assembling cytotoxic IS. |
| | |
Authors:
|
Marcus Lettau; Jing Qian; Andreas Linkermann; Mathieu Latreille; Louise Larose; Dieter Kabelitz; Ottmar Janssen |
Related Documents
:
|
12667615 - The impact of n- and o-glycosylation on the functions of glut-1 transporter in human th... 20188745 - Protective effect of nicotinamide against poly(adp-ribose) polymerase-1-mediated astroc... 7713875 - Distinguishing between folate receptor-alpha-mediated transport and reduced folate carr... 7067885 - The influence of embryonic testosterone treatment on bursal epithelial pinocytotic acti... 15120035 - In vitro modelling of human tumour behaviour in drug discovery programmes. 19373935 - Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-04-04 |
Journal Detail:
|
Title: Proceedings of the National Academy of Sciences of the United States of America Volume: 103 ISSN: 0027-8424 ISO Abbreviation: Proc. Natl. Acad. Sci. U.S.A. Publication Date: 2006 Apr |
Date Detail:
|
Created Date: 2006-04-12 Completed Date: 2006-06-09 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 7505876 Medline TA: Proc Natl Acad Sci U S A Country: United States |
Other Details:
|
Languages: eng Pagination: 5911-6 Citation Subset: IM |
Affiliation:
|
Institute for Immunology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adaptor Proteins, Signal Transducing Apoptosis Regulatory Proteins / immunology* Binding Sites CD4-Positive T-Lymphocytes / immunology* Cell Line Clone Cells Cytotoxicity, Immunologic Fas Ligand Protein Humans Lysosomes / immunology* Membrane Glycoproteins / metabolism* Oncogene Proteins / metabolism* Protein Binding Recombinant Fusion Proteins / metabolism Recombinant Proteins / metabolism T-Lymphocytes, Cytotoxic / immunology* Transfection Tumor Necrosis Factors / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Adaptor Proteins, Signal Transducing; 0/Apoptosis Regulatory Proteins; 0/FASLG protein, human; 0/Fas Ligand Protein; 0/Membrane Glycoproteins; 0/Nck protein; 0/Oncogene Proteins; 0/Recombinant Fusion Proteins; 0/Recombinant Proteins; 0/Tumor Necrosis Factors |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superox...
Next Document: Antiviral options for the treatment of chronic hepatitis B.